NDC 64764-516 - VONVENDI
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 64764-516
- Package NDCs from labels
- 64764-516-10
- Manufacturer
- Takeda Pharmaceuticals America, Inc. | Baxalta US Inc. | Siegfried Hameln GmbH | Baxalta Manufacturing Sàrl
- Effective date
- 2026-07-28
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| VONVENDI | Takeda Pharmaceuticals America, Inc. | Baxalta US Inc. | Siegfried Hameln GmbH | Baxalta Manufacturing Sàrl | 2026-07-28 | PLASMA DERIVATIVE |
| CEPROTIN - Takeda Pharmaceuticals America, Inc. | Takeda Manufacturing Austria AG | Siegfried Hameln GmbH | Takeda Pharmaceuticals America, Inc. | Takeda Manufacturing Austria AG | Siegfried Hameln GmbH | 2025-12-04 | PLASMA DERIVATIVE |
| FEIBA - Takeda Pharmaceuticals America, Inc. | Takeda Manufacturing Austria AG | Siegfried Hameln GmbH | Takeda Pharmaceuticals America, Inc. | Takeda Manufacturing Austria AG | Siegfried Hameln GmbH | 2025-11-27 | HUMAN PRESCRIPTION DRUG LABEL |
| HEMOFIL M - Takeda Pharmaceuticals America, Inc. | BAXALTA US Inc. | Takeda Pharmaceuticals America, Inc. | BAXALTA US Inc. | 2025-03-06 | PLASMA DERIVATIVE |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 64764-516 | FEIBA (ANTI-INHIBITOR COAGULANT COMPLEX) KIT [TAKEDA PHARMACEUTICALS AMERICA, INC.] | 29 | Unmatched | 20250109_752604e5-4ea2-44f4-83ed-1569373f6412.zip |
| 64764-516 | VONVENDI (VON WILLEBRAND FACTOR (RECOMBINANT)) KIT [TAKEDA PHARMACEUTICALS AMERICA, INC.] | 17 | Unmatched | 20230418_53b6d198-6175-4a26-8606-dc0d2a0f12d6.zip |
| 64764-516 | HEMOFIL M (ANTIHEMOPHILIC FACTOR HUMAN) KIT [TAKEDA PHARMACEUTICALS AMERICA, INC.] | 15 | Unmatched | 20250309_b8953ff7-3bba-4a0b-a486-f26fb81f05d9.zip |
| 64764-516 | CEPROTIN (PROTEIN C CONCENTRATE HUMAN) KIT [TAKEDA PHARMACEUTICALS AMERICA, INC.] | 14 | Unmatched | 20250110_926914a9-78b2-40ea-b37d-2a55c09bf275.zip |
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Anxiety | BORAX, NATRUM MURIATICUM, CAUSTICUM, ELETTARIA CARDAMOMUM, PLUMBUM METALLICUM, SEPIA, LILIUM TIGRINUM, OXYTROPIS LAMBERTII | Nutritional Specialties, Inc. | 657ed32f-3ac7-4806-96b4-4c7aa0f65e7f | 2023-04-03 | Warnings | 451W47IQ8X |
| Virility Liquescence | AVENA SATIVA, DAMIANA, BERBERIS VULGARIS, EPIMEDIUM GRANDIFLORUM, GLYCERINUM, SABAL SERRULATA, IODIUM, LECITHIN, FERRUM MURIATICUM, NATRUM MURIATICUM, AGNUS CASTUS, BUFO RANA, CINCHONA OFFICINALIS, HUMAN GROWTH HORMONE (HGH), ORCHITINUM (BOVINE), PHOSPHORICUM ACIDUM, PHOSPHORUS, SELENIUM METALLICUM, ZINCUM VALERIANICUM, OOPHORINUM (SUIS), SEPIA | Nutritional Specialties, Inc. | 81cc3e2b-f95e-4ba4-a15f-c07b4def0e2f | 2023-03-29 | Warnings | 451W47IQ8X |
| Spleen Thymus Liquescence | CINCHONA OFFICINALIS, QUERCUS GLANDIUM SPIRITUS, CEANOTHUS AMERICANUS, SPLEEN (BOVINE), THYMUS (BOVINE), CHININUM ARSENICOSUM, NATRUM MURIATICUM, HELIANTHUS ANNUUS | Nutritional Specialties, Inc. | bc1cc31e-0e8a-49a2-9654-f00eaa72fc04 | 2023-03-24 | Warnings | 451W47IQ8X |
| Emetrol Chewables Mixed Berry | SODIUM CITRATE DIHYDRATE | WellSpring Pharmaceutical Corporation | 4965fab0-828d-4f1d-8d43-a636e0a8c1ea | 2023-03-23 | Warnings | B22547B95K |
| Emetrol Chewables Orange | SODIUM CITRATE DIHYDRATE | WellSpring Pharmaceutical Corporation | e9072f9d-d74c-4e43-bcfe-ee005577df35 | 2023-03-23 | Warnings | B22547B95K |
| Mannitol | MANNITOL | Fresenius Kabi USA, LLC | c395e13d-6ea1-4104-8b37-669cfb982f04 | 2023-03-16 | Warnings, Adverse reactions | 3OWL53L36A |
| NOVOLOG | INSULIN ASPART | Novo Nordisk | 3a1e73a2-3009-40d0-876c-b4cb2be56fc5 | 2023-02-28 | Warnings, Adverse reactions | 059QF0KO0R |
| Natrum muriaticum | SODIUM CHLORIDE | Boiron | 1ef4a040-7bee-11e6-8371-424c58303031 | 2023-02-20 | 451W47IQ8X | |
| Natrum muriaticum | SODIUM CHLORIDE | Boiron | 8645e304-a71b-5cba-e053-2a91aa0a2d88 | 2023-02-20 | 451W47IQ8X | |
| EyeClear Pro | CALC CARB, CALC FLUOR, CAUSTICUM, CINERARIA, EUPHRASIA, NAPHTHALINUM, NAT MUR, PHOS, QUASSIA, SILICEA | Silver Star Brands | f4d4943b-cb78-aa71-e053-2a95a90ac638 | 2023-02-16 | Warnings | 451W47IQ8X |
| triCitrasol | TRISODIUM CITRATE DIHYDRATE | Citra Labs LLC | 64e7652c-1437-43bd-8ea2-3cafab447b8c | 2023-02-14 | Warnings, Adverse reactions | B22547B95K |
| Anticoagulant Citrate Dextrose A | ANHYDROUS CITRIC ACID, DEXTROSE MONOHYDRATE, AND TRISODIUM CITRATE DIHYDRATE | Citra Labs LLC | 5bcd261e-ebba-4ecb-af22-e5aaeb04499b | 2023-02-14 | Warnings, Adverse reactions | B22547B95K |
| laxative | POLYETHYLENE GLYCOL 3350 | Rite Aid Corporation | 3ebe9191-8e0a-41cf-b759-82ecce4f50e4 | 2023-02-10 | Warnings | G2M7P15E5P |
| POLYETHYLENE GLYCOL-3350 AND ELECTROLYTES | POLYETHYLENE GLYCOL-3350 AND ELECTROLYTES | Novel Laboratories, Inc. | 29d821ff-389c-41fb-8a27-89bd3f022b82 | 2023-02-08 | Warnings, Adverse reactions | 451W47IQ8X G2M7P15E5P |
| dg health clearlax | POLYETHYLENE GLYCOL 3350 | Dolgencorp, LLC | 94280ce4-b2cf-451d-a660-b26ab1a2d3f0 | 2023-02-06 | Warnings | G2M7P15E5P |
| clearlax | POLYETHYLENE GLYCOL 3350 | H E B | 0b4b752d-045d-4ff0-8e50-5607d1a841a7 | 2023-01-26 | Warnings | G2M7P15E5P |
| Good Sense Clear Lax | POLYETHYLENE GLYCOL 3350 | L. Perrigo Company | 435db89c-1e32-4da5-b7d0-15e407162715 | 2023-01-24 | Warnings | G2M7P15E5P |
| Natrum muriaticum | SODIUM CHLORIDE | Boiron | 86463b98-58f5-7f65-e053-2a91aa0ad3a2 | 2023-01-23 | 451W47IQ8X | |
| Natrum muriaticum | SODIUM CHLORIDE | Boiron | 8645f130-6a19-ae73-e053-2991aa0ab05b | 2023-01-23 | 451W47IQ8X | |
| Natrum muriaticum | SODIUM CHLORIDE | Boiron | 8645eb60-65d1-9d6c-e053-2991aa0a94ef | 2023-01-23 | 451W47IQ8X |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.